AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇨🇮
RITUXIMAB in Côte d'Ivoire
7 products registered with AIRP — 3 active, 4 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MABTHERA 500MG/50ML SOLUTION A DILUER POUR PERFUSION BOITE DE 2 | E-2002-0089 | F. HOFFMANN-LA ROCHE LTD | active | 30 Oct 2027 |
| MABTHERA 100MG/10ML SOLUTION A DILUER POUR PERFUSION BOITE DE 2 | E-2002-0090 | F. HOFFMANN-LA ROCHE LTD | active | 30 Oct 2027 |
| MABTHERA 1400MG/11,7 ML SC SOLUTION A DILUER POUR PERFUSION BOITE DE 1 | E-2022-0043 | F. HOFFMANN-LA ROCHE LTD | active | 25 May 2027 |
| RILAST 100MG/10ML SOLUTION POUR INJECTABLEION SOUS-CUTANEE BOITE DE 1 | E-2018-0387 | HETERO LABS LIMITED | expired | 24 Jan 2023 |
| ZELVA 100MG/10ML SOLUTION A DILUER POUR PERFUSION BOITE DE 2 | MD/201824-0173 | SOTHEMA | expired | 24 Jan 2023 |
| RILAST 500MG/50ML SOLUTION POUR INJECTABLEION SOUS-CUTANEE BOITE DE 1 | E-2018-0388 | HETERO LABS LIMITED | expired | 24 Jan 2023 |
| ZELVA 500MG/50ML SOLUTION A DILUER POUR PERFUSION FLACON DE 50ML | MD/201824-0174 | SOTHEMA | expired | 24 Jan 2023 |
RITUXIMAB — AIRP Registration Details
AIRP (Côte d'Ivoire) has 7 registered products containing RITUXIMAB, of which 3 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.
Track RITUXIMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.